Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

2.1K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

492
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
492
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

1.7K
Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
1.7K
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

4.6K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.6K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

1.2K
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.2K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

1.3K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Idiopathic Inflammatory Myopathies.

Continuum (Minneapolis, Minn.)·2025
Same author

Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.

JAMA·2025
Same author

Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.

JAMA network open·2025
Same author

Neuroprognostication for Patients with Amyotrophic Lateral Sclerosis: An Updated, Evidence-Based Review.

Seminars in neurology·2023
Same author

Development and Dissemination of a Neurology Palliative Care Curriculum: Education in Palliative and End-of-Life Care Neurology.

Neurology. Clinical practice·2022
Same author

Utility of the ALSFRS-R for predicting ALS and comorbid disease neuropathology: The Veterans Affairs Biorepository Brain Bank.

Muscle & nerve·2022

Related Experiment Video

Updated: Feb 7, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.1K

Motor Neuron Disease: Pathophysiology, Diagnosis, and Management.

Laura A Foster1, Mohammad Kian Salajegheh2

  • 1Department of Medicine/Division of Palliative Care and Geriatric Medicine, Massachusetts General Hospital, Boston.

The American Journal of Medicine
|August 4, 2018
PubMed
Summary

Diagnosing motor neuron diseases (MNDs) promptly is crucial for effective treatment. This review offers primary care physicians a framework for identifying and evaluating MNDs, including amyotrophic lateral sclerosis.

Keywords:
Amyotrophic lateral sclerosisKennedy diseaseMotor neuron diseasePoliomyelitis

More Related Videos

Extracellularly Identifying Motor Neurons for a Muscle Motor Pool in Aplysia californica
13:37

Extracellularly Identifying Motor Neurons for a Muscle Motor Pool in Aplysia californica

Published on: March 25, 2013

12.2K
Preparation of Aplysia Sensory-motor Neuronal Cell Cultures
17:27

Preparation of Aplysia Sensory-motor Neuronal Cell Cultures

Published on: June 8, 2009

16.5K

Related Experiment Videos

Last Updated: Feb 7, 2026

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
15:48

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

10.1K
Extracellularly Identifying Motor Neurons for a Muscle Motor Pool in Aplysia californica
13:37

Extracellularly Identifying Motor Neurons for a Muscle Motor Pool in Aplysia californica

Published on: March 25, 2013

12.2K
Preparation of Aplysia Sensory-motor Neuronal Cell Cultures
17:27

Preparation of Aplysia Sensory-motor Neuronal Cell Cultures

Published on: June 8, 2009

16.5K

Area of Science:

  • Neurology
  • Primary Care Medicine

Background:

  • Motor neuron diseases (MNDs) require timely diagnosis for early intervention.
  • Accurate diagnosis is critical, especially for amyotrophic lateral sclerosis (ALS) due to its poor prognosis.

Purpose of the Study:

  • To provide primary care physicians with a clinical and diagnostic framework.
  • To aid in the early identification and evaluation of motor neuron diseases.

Main Methods:

  • This is a review article.
  • Focuses on clinical presentation and diagnostic strategies relevant to primary care.

Main Results:

  • The review outlines key diagnostic criteria and evaluation steps for MNDs.
  • Highlights the importance of recognizing subtle signs in primary care settings.

Conclusions:

  • A structured approach can improve the timely and accurate diagnosis of MNDs.
  • Empowering primary care physicians is essential for better patient outcomes in motor neuron disease management.